Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Hologic, Inc. stock logo
HOLX
Hologic
$64.62
-1.7%
$61.55
$51.90
$84.67
$14.40B0.552.38 million shs1.69 million shs
Insulet Corporation stock logo
PODD
Insulet
$292.01
+0.9%
$307.29
$173.00
$329.33
$20.55B1.35717,990 shs605,791 shs
Universal Health Services, Inc. stock logo
UHS
Universal Health Services
$183.49
+0.5%
$183.88
$153.99
$243.25
$11.93B1.28785,952 shs493,166 shs
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$224.66
-1.1%
$217.07
$187.43
$352.33
$16.14B1.09733,013 shs340,995 shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Hologic, Inc. stock logo
HOLX
Hologic
-1.67%+0.39%-0.20%+11.68%-16.82%
Insulet Corporation stock logo
PODD
Insulet
+0.93%-2.89%-4.14%+13.88%+44.57%
Universal Health Services, Inc. stock logo
UHS
Universal Health Services
+0.50%+1.23%+7.33%+4.67%-0.51%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
-1.00%+1.43%+1.30%+5.78%-30.44%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Hologic, Inc. stock logo
HOLX
Hologic
4.7249 of 5 stars
3.23.00.04.32.83.31.9
Insulet Corporation stock logo
PODD
Insulet
4.252 of 5 stars
2.43.00.04.93.40.81.9
Universal Health Services, Inc. stock logo
UHS
Universal Health Services
4.991 of 5 stars
3.25.01.74.63.33.33.8
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
4.749 of 5 stars
3.45.01.73.21.51.71.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Hologic, Inc. stock logo
HOLX
Hologic
2.47
Hold$78.7521.87% Upside
Insulet Corporation stock logo
PODD
Insulet
2.83
Moderate Buy$321.009.93% Upside
Universal Health Services, Inc. stock logo
UHS
Universal Health Services
2.40
Hold$224.7722.50% Upside
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
2.89
Moderate Buy$320.0042.43% Upside

Current Analyst Ratings Breakdown

Latest HOLX, PODD, UHS, WST, and COH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/9/2025
Hologic, Inc. stock logo
HOLX
Hologic
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$60.00 ➝ $80.00
7/8/2025
Insulet Corporation stock logo
PODD
Insulet
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
7/8/2025
Hologic, Inc. stock logo
HOLX
Hologic
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetIn-Line ➝ In-Line$62.00 ➝ $68.00
6/24/2025
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageEqual Weight$245.00
6/16/2025
Insulet Corporation stock logo
PODD
Insulet
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$365.00
6/2/2025
Universal Health Services, Inc. stock logo
UHS
Universal Health Services
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
5/30/2025
Insulet Corporation stock logo
PODD
Insulet
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$380.00
5/27/2025
Hologic, Inc. stock logo
HOLX
Hologic
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
5/27/2025
Insulet Corporation stock logo
PODD
Insulet
Raymond James Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$328.00 ➝ $360.00
5/22/2025
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
5/22/2025
Insulet Corporation stock logo
PODD
Insulet
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$320.00 ➝ $380.00
(Data available from 7/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Hologic, Inc. stock logo
HOLX
Hologic
$4.03B3.57$5.41 per share11.95$22.09 per share2.93
Insulet Corporation stock logo
PODD
Insulet
$2.07B9.92$4.48 per share65.21$17.27 per share16.91
Universal Health Services, Inc. stock logo
UHS
Universal Health Services
$15.83B0.75$26.79 per share6.85$104.94 per share1.75
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$2.89B5.58$8.91 per share25.21$37.04 per share6.07
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Hologic, Inc. stock logo
HOLX
Hologic
$789.50M$2.3727.2713.992.4113.83%19.71%10.87%7/30/2025 (Estimated)
Insulet Corporation stock logo
PODD
Insulet
$418.30M$5.5652.5258.752.5818.29%22.25%8.29%8/7/2025 (Confirmed)
Universal Health Services, Inc. stock logo
UHS
Universal Health Services
$1.14B$17.8210.3010.370.747.44%17.79%8.27%7/23/2025 (Estimated)
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$492.70M$6.3735.2728.585.5916.13%18.23%13.51%7/24/2025 (Estimated)

Latest HOLX, PODD, UHS, WST, and COH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/30/2025Q3 2025
Hologic, Inc. stock logo
HOLX
Hologic
$1.05N/AN/AN/A$1.01 billionN/A
7/24/2025Q2 2025
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$1.51N/AN/AN/A$725.11 millionN/A
7/23/2025Q2 2025
Universal Health Services, Inc. stock logo
UHS
Universal Health Services
$4.87N/AN/AN/A$4.24 billionN/A
5/8/2025Q1 2025
Insulet Corporation stock logo
PODD
Insulet
$0.81$1.02+$0.21$0.50$543.20 million$569.00 million
5/1/2025Q2 2025
Hologic, Inc. stock logo
HOLX
Hologic
$1.02$1.03+$0.01-$0.08$1.00 billion$1.01 billion
4/28/2025Q1 2025
Universal Health Services, Inc. stock logo
UHS
Universal Health Services
$4.36$4.84+$0.48$4.80$4.16 billion$4.10 billion
4/24/2025Q1 2025
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$1.22$1.45+$0.23$1.23$685.24 million$698.00 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Hologic, Inc. stock logo
HOLX
Hologic
N/AN/AN/AN/AN/A
Insulet Corporation stock logo
PODD
Insulet
N/AN/AN/AN/AN/A
Universal Health Services, Inc. stock logo
UHS
Universal Health Services
$0.800.44%N/A4.49%N/A
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$0.840.37%N/A13.19%N/A

Latest HOLX, PODD, UHS, WST, and COH Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/24/2025
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
quarterly$0.210.39%7/30/20257/30/20258/6/2025
5/14/2025
Universal Health Services, Inc. stock logo
UHS
Universal Health Services
quarterly$0.200.43%6/2/20256/2/20256/16/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Hologic, Inc. stock logo
HOLX
Hologic
0.54
3.24
2.52
Insulet Corporation stock logo
PODD
Insulet
1.21
4.47
3.63
Universal Health Services, Inc. stock logo
UHS
Universal Health Services
0.67
1.32
1.23
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
0.08
2.77
2.03

Institutional Ownership

CompanyInstitutional Ownership
Hologic, Inc. stock logo
HOLX
Hologic
94.73%
Insulet Corporation stock logo
PODD
Insulet
N/A
Universal Health Services, Inc. stock logo
UHS
Universal Health Services
86.05%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
93.90%

Insider Ownership

CompanyInsider Ownership
Hologic, Inc. stock logo
HOLX
Hologic
1.88%
Insulet Corporation stock logo
PODD
Insulet
0.39%
Universal Health Services, Inc. stock logo
UHS
Universal Health Services
16.40%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
0.57%
CompanyEmployeesShares OutstandingFree FloatOptionable
Hologic, Inc. stock logo
HOLX
Hologic
7,063222.85 million218.66 millionOptionable
Insulet Corporation stock logo
PODD
Insulet
3,90070.38 million70.10 millionOptionable
Universal Health Services, Inc. stock logo
UHS
Universal Health Services
99,00065.00 million54.34 millionOptionable
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
10,60071.85 million71.44 millionOptionable

Recent News About These Companies

West to Host Second-Quarter 2025 Conference Call

New MarketBeat Followers Over Time

Media Sentiment Over Time

Hologic stock logo

Hologic NASDAQ:HOLX

$64.62 -1.10 (-1.67%)
Closing price 07/14/2025 04:00 PM Eastern
Extended Trading
$64.58 -0.04 (-0.05%)
As of 07/14/2025 05:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and connectivity solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, the company offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Insulet stock logo

Insulet NASDAQ:PODD

$292.01 +2.69 (+0.93%)
Closing price 07/14/2025 04:00 PM Eastern
Extended Trading
$292.03 +0.02 (+0.01%)
As of 07/14/2025 07:08 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Universal Health Services stock logo

Universal Health Services NYSE:UHS

$183.49 +0.97 (+0.53%)
Closing price 07/14/2025 03:59 PM Eastern
Extended Trading
$183.46 -0.03 (-0.02%)
As of 07/14/2025 07:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services. It also provides commercial health insurance services; and various management services, which include central purchasing, information, finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing, and public relations services. Universal Health Services, Inc. founded in 1978 and is headquartered in King of Prussia, Pennsylvania.

West Pharmaceutical Services stock logo

West Pharmaceutical Services NYSE:WST

$224.66 -2.52 (-1.11%)
Closing price 07/14/2025 03:59 PM Eastern
Extended Trading
$226.00 +1.34 (+0.60%)
As of 07/14/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.